Comparing GLP-1 Dosing Flexibility Not all weight loss medications follow the same rules
Retatrutide's Phase 3 program started in 2024, so a 2027 to 2028 obesity approval lines up cleanly with the same four-year arc
Tesamorelin (GHRH analog for visceral fat), MOTS-C (mitochondrial AMPK activation), and BPC-157 (connective tissue support during caloric restriction) are popular adds
Suitable for Vegans and Vegetarians
Other reported side effects include: a change in taste, muscle loss, and weight regain if the person stops using the drug
This week were on spring break in Costa Rica, where I had something called a sculptural facial which is less a facial and more a deep face, neck, and shoulder massage with lymphatic drainage